Industry Research Reports
Home > Reports > Chemical & Material > Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-03-05
Pages: 128 Pages
Report ld: 6011297
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Enflurane was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enflurane cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Enflurane is an inhalational anesthetic, belonging to the class of halogenated ethers. It works by inhibiting the central nervous system, rendering patients pain-free and unconscious during surgical procedures. Enflurane is characterized by its rapid onset, strong controllability, and minimal impact on the respiratory and circulatory systems. It is widely used in clinical anesthesia. The market for Enflurane is primarily concentrated in medical institutions and operating rooms. With the advancement of medical technology and the increase in surgical procedures, the demand for Enflurane is also evolving. In recent years, the market share of Enflurane has declined due to the emergence of newer anesthetics. However, it still holds irreplaceable value in specific surgical scenarios. From an industry perspective, the research and development of Enflurane involve not only its pharmacological properties but also its market positioning, competitive landscape, and future development trends.
Market Development Opportunities & Main Driving Factors
The market development opportunities for Enflurane are mainly reflected in several aspects. Firstly, with the increasing global aging population and the growing number of chronic disease patients, the demand for surgeries is also rising, providing a stable market base for Enflurane. Secondly, despite the emergence of new anesthetics, Enflurane still has unique advantages in certain specific surgical scenarios, such as short-duration surgeries and surgeries with lower requirements for respiratory depression. Additionally, the continuous improvement of medical infrastructure and increasing investment in medical resources in developing countries offer new space for the market expansion of Enflurane. These factors collectively drive the continuous development of the Enflurane market.
Market Challenges, Risks, & Restraints
The market for Enflurane also faces numerous challenges and risks. On the one hand, the continuous introduction of new anesthetics has impacted the market share of Enflurane. These new anesthetics may have advantages in terms of safety and side effect control, leading some medical institutions to reduce their use of Enflurane. On the other hand, strict pharmaceutical regulatory policies and environmental requirements have increased the production costs and market access difficulties for Enflurane. Moreover, with intense market competition, companies need to continuously improve their competitiveness in product quality, price, and service to cope with pressure from domestic and international peers.
Downstream Demand Trends
From the perspective of downstream demand trends, the market demand for Enflurane will gradually shift towards refinement and specialization. As medical technology advances and the complexity and precision requirements of surgeries increase, medical institutions will place greater emphasis on the adaptability and safety of anesthetics. In the future, Enflurane is likely to be used more in specific types of surgeries, such as those for elderly patients or in certain specialized departments. Meanwhile, with the development of medical informatization, medical institutions will have more standardized and transparent procurement and usage management of anesthetics, which will also pose higher requirements for the market promotion of Enflurane.
This report provides a comprehensive view of the global market for Enflurane, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Enflurane market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Enflurane.
MARKET SEGMENTATION
By Company
- Baxter
- J&TEC
- GE Healthcare
- Gasera
- Draeger
- Abbott
- AstraZeneca
- Sanofi
- Pfizer
- Johnson & Johnson
- Merck
- Roche
- Novartis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pharmaceutical Grade Enflurane
- Industrial Grade Enflurane
Segment by Application
- Medicine
- Chemical Industry
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Enflurane manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Enflurane sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Enflurane sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Enflurane Product Introduction
1.2 Global Enflurane Market Size Forecast
1.2.1 Global Enflurane Sales Value (2021–2032)
1.2.2 Global Enflurane Sales Volume (2021–2032)
1.2.3 Global Enflurane Sales Price (2021–2032)
1.3 Enflurane Market Trends & Drivers
1.3.1 Enflurane Industry Trends
1.3.2 Enflurane Market Drivers & Opportunities
1.3.3 Enflurane Market Challenges
1.3.4 Enflurane Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enflurane Players Revenue Ranking (2025)
2.2 Global Enflurane Revenue by Company (2021–2026)
2.3 Global Enflurane Sales Volume Ranking of Players (2025)
2.4 Global Enflurane Sales Volume by Company (2021–2026)
2.5 Global Enflurane Average Price by Company (2021–2026)
2.6 Key Manufacturers Enflurane Manufacturing Base and Headquarters
2.7 Key Manufacturers Enflurane Product Offerings
2.8 Key Manufacturers Start of Mass Production of Enflurane
2.9 Enflurane Market Competitive Analysis
2.9.1 Enflurane Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Enflurane Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Enflurane revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Enflurane Market Classification
3.1 Introduction by Type
3.1.1 Pharmaceutical Grade Enflurane
3.1.2 Industrial Grade Enflurane
3.1.3 Global Enflurane Sales Value by Type
3.1.3.1 Global Enflurane Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Enflurane Sales Value, by Type (2021–2032)
3.1.3.3 Global Enflurane Sales Value, by Type (%), 2021–2032
3.1.4 Global Enflurane Sales Volume by Type
3.1.4.1 Global Enflurane Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Enflurane Sales Volume, by Type (2021–2032)
3.1.4.3 Global Enflurane Sales Volume, by Type (%), 2021–2032
3.1.5 Global Enflurane Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Chemical Industry
4.1.3 Others
4.2 Global Enflurane Sales Value by Application
4.2.1 Global Enflurane Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Enflurane Sales Value, by Application (2021–2032)
4.2.3 Global Enflurane Sales Value, by Application (%), 2021–2032
4.3 Global Enflurane Sales Volume by Application
4.3.1 Global Enflurane Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Enflurane Sales Volume, by Application (2021–2032)
4.3.3 Global Enflurane Sales Volume, by Application (%), 2021–2032
4.4 Global Enflurane Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Enflurane Sales Value by Region
5.1.1 Global Enflurane Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Enflurane Sales Value by Region (2021–2026)
5.1.3 Global Enflurane Sales Value by Region (2027–2032)
5.1.4 Global Enflurane Sales Value by Region (%), 2021–2032
5.2 Global Enflurane Sales Volume by Region
5.2.1 Global Enflurane Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Enflurane Sales Volume by Region (2021–2026)
5.2.3 Global Enflurane Sales Volume by Region (2027–2032)
5.2.4 Global Enflurane Sales Volume by Region (%), 2021–2032
5.3 Global Enflurane Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Enflurane Sales Value, 2021–2032
5.4.2 North America Enflurane Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Enflurane Sales Value, 2021–2032
5.5.2 Europe Enflurane Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Enflurane Sales Value, 2021–2032
5.6.2 Asia Pacific Enflurane Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Enflurane Sales Value, 2021–2032
5.7.2 South America Enflurane Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enflurane Sales Value, 2021–2032
5.8.2 Middle East & Africa Enflurane Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enflurane Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Enflurane Sales Value and Sales Volume
6.2.1 Key Countries/Regions Enflurane Sales Value, 2021–2032
6.2.2 Key Countries/Regions Enflurane Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Enflurane Sales Value, 2021–2032
6.3.2 United States Enflurane Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Enflurane Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Enflurane Sales Value, 2021–2032
6.4.2 Europe Enflurane Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Enflurane Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Enflurane Sales Value, 2021–2032
6.5.2 China Enflurane Sales Value by Type (%), 2025 vs 2032
6.5.3 China Enflurane Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Enflurane Sales Value, 2021–2032
6.6.2 Japan Enflurane Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Enflurane Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Enflurane Sales Value, 2021–2032
6.7.2 South Korea Enflurane Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Enflurane Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Enflurane Sales Value, 2021–2032
6.8.2 Southeast Asia Enflurane Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Enflurane Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Enflurane Sales Value, 2021–2032
6.9.2 India Enflurane Sales Value by Type (%), 2025 vs 2032
6.9.3 India Enflurane Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Introduction and Business Overview
7.1.3 Baxter Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Baxter Enflurane Product Offerings
7.1.5 Baxter Recent Developments
7.2 J&TEC
7.2.1 J&TEC Company Information
7.2.2 J&TEC Introduction and Business Overview
7.2.3 J&TEC Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 J&TEC Enflurane Product Offerings
7.2.5 J&TEC Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Company Information
7.3.2 GE Healthcare Introduction and Business Overview
7.3.3 GE Healthcare Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 GE Healthcare Enflurane Product Offerings
7.3.5 GE Healthcare Recent Developments
7.4 Gasera
7.4.1 Gasera Company Information
7.4.2 Gasera Introduction and Business Overview
7.4.3 Gasera Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Gasera Enflurane Product Offerings
7.4.5 Gasera Recent Developments
7.5 Draeger
7.5.1 Draeger Company Information
7.5.2 Draeger Introduction and Business Overview
7.5.3 Draeger Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Draeger Enflurane Product Offerings
7.5.5 Draeger Recent Developments
7.6 Abbott
7.6.1 Abbott Company Information
7.6.2 Abbott Introduction and Business Overview
7.6.3 Abbott Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Abbott Enflurane Product Offerings
7.6.5 Abbott Recent Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Information
7.7.2 AstraZeneca Introduction and Business Overview
7.7.3 AstraZeneca Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 AstraZeneca Enflurane Product Offerings
7.7.5 AstraZeneca Recent Developments
7.8 Sanofi
7.8.1 Sanofi Company Information
7.8.2 Sanofi Introduction and Business Overview
7.8.3 Sanofi Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Sanofi Enflurane Product Offerings
7.8.5 Sanofi Recent Developments
7.9 Pfizer
7.9.1 Pfizer Company Information
7.9.2 Pfizer Introduction and Business Overview
7.9.3 Pfizer Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Pfizer Enflurane Product Offerings
7.9.5 Pfizer Recent Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Information
7.10.2 Johnson & Johnson Introduction and Business Overview
7.10.3 Johnson & Johnson Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Johnson & Johnson Enflurane Product Offerings
7.10.5 Johnson & Johnson Recent Developments
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Merck Enflurane Product Offerings
7.11.5 Merck Recent Developments
7.12 Roche
7.12.1 Roche Company Information
7.12.2 Roche Introduction and Business Overview
7.12.3 Roche Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Roche Enflurane Product Offerings
7.12.5 Roche Recent Developments
7.13 Novartis
7.13.1 Novartis Company Information
7.13.2 Novartis Introduction and Business Overview
7.13.3 Novartis Enflurane Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Novartis Enflurane Product Offerings
7.13.5 Novartis Recent Developments
8 Industry Chain Analysis
8.1 Enflurane Industrial Chain
8.2 Enflurane Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Enflurane Sales Model
8.5.2 Sales Channels
8.5.3 Enflurane Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Enflurane Market Trends
Table 2. Enflurane Market Drivers & Opportunities
Table 3. Enflurane Market Challenges
Table 4. Enflurane Market Restraints
Table 5. Global Enflurane Revenue by Company (US$ Million), 2021–2026
Table 6. Global Enflurane Revenue Market Share by Company (2021–2026)
Table 7. Global Enflurane Sales Volume by Company (MT), 2021–2026
Table 8. Global Enflurane Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Enflurane Price by Company (USD/MT), 2021–2026
Table 10. Key Manufacturers Enflurane Manufacturing Base and Headquarters
Table 11. Key Manufacturers Enflurane Product Type
Table 12. Key Manufacturers Start of Mass Production of Enflurane
Table 13. Global Enflurane Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Enflurane revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Enflurane Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Enflurane Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Enflurane Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Enflurane Sales Market Share in Value by Type (2021–2026)
Table 20. Global Enflurane Sales Market Share in Value by Type (2027–2032)
Table 21. Global Enflurane Sales Volume by Type: 2021 vs 2025 vs 2032 (MT)
Table 22. Global Enflurane Sales Volume by Type (MT), 2021–2026
Table 23. Global Enflurane Sales Volume by Type (MT), 2027–2032
Table 24. Global Enflurane Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Enflurane Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Enflurane Price by Type (USD/MT), 2021–2026
Table 27. Global Enflurane Price by Type (USD/MT), 2027–2032
Table 28. Global Enflurane Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Enflurane Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Enflurane Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Enflurane Sales Market Share in Value by Application (2021–2026)
Table 32. Global Enflurane Sales Market Share in Value by Application (2027–2032)
Table 33. Global Enflurane Sales Volume by Application: 2021 vs 2025 vs 2032 (MT)
Table 34. Global Enflurane Sales Volume by Application (MT), 2021–2026
Table 35. Global Enflurane Sales Volume by Application (MT), 2027–2032
Table 36. Global Enflurane Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Enflurane Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Enflurane Price by Application (USD/MT), 2021–2026
Table 39. Global Enflurane Price by Application (USD/MT), 2027–2032
Table 40. Global Enflurane Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Enflurane Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Enflurane Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Enflurane Sales Value by Region (%), 2021–2026
Table 44. Global Enflurane Sales Value by Region (%), 2027–2032
Table 45. Global Enflurane Sales Volume by Region (MT): 2021 vs 2025 vs 2032
Table 46. Global Enflurane Sales Volume by Region (MT), 2021–2026
Table 47. Global Enflurane Sales Volume by Region (MT), 2027–2032
Table 48. Global Enflurane Sales Volume by Region (%), 2021–2026
Table 49. Global Enflurane Sales Volume by Region (%), 2027–2032
Table 50. Global Enflurane Average Price by Region (USD/MT), 2021–2026
Table 51. Global Enflurane Average Price by Region (USD/MT), 2027–2032
Table 52. Key Countries/Regions Enflurane Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Enflurane Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Enflurane Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Enflurane Sales Volume, (MT), 2021–2026
Table 56. Key Countries/Regions Enflurane Sales Volume, (MT), 2027–2032
Table 57. Baxter Company Information
Table 58. Baxter Introduction and Business Overview
Table 59. Baxter Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 60. Baxter Enflurane Product Offerings
Table 61. Baxter Recent Developments
Table 62. J&TEC Company Information
Table 63. J&TEC Introduction and Business Overview
Table 64. J&TEC Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 65. J&TEC Enflurane Product Offerings
Table 66. J&TEC Recent Developments
Table 67. GE Healthcare Company Information
Table 68. GE Healthcare Introduction and Business Overview
Table 69. GE Healthcare Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 70. GE Healthcare Enflurane Product Offerings
Table 71. GE Healthcare Recent Developments
Table 72. Gasera Company Information
Table 73. Gasera Introduction and Business Overview
Table 74. Gasera Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 75. Gasera Enflurane Product Offerings
Table 76. Gasera Recent Developments
Table 77. Draeger Company Information
Table 78. Draeger Introduction and Business Overview
Table 79. Draeger Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 80. Draeger Enflurane Product Offerings
Table 81. Draeger Recent Developments
Table 82. Abbott Company Information
Table 83. Abbott Introduction and Business Overview
Table 84. Abbott Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 85. Abbott Enflurane Product Offerings
Table 86. Abbott Recent Developments
Table 87. AstraZeneca Company Information
Table 88. AstraZeneca Introduction and Business Overview
Table 89. AstraZeneca Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 90. AstraZeneca Enflurane Product Offerings
Table 91. AstraZeneca Recent Developments
Table 92. Sanofi Company Information
Table 93. Sanofi Introduction and Business Overview
Table 94. Sanofi Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 95. Sanofi Enflurane Product Offerings
Table 96. Sanofi Recent Developments
Table 97. Pfizer Company Information
Table 98. Pfizer Introduction and Business Overview
Table 99. Pfizer Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 100. Pfizer Enflurane Product Offerings
Table 101. Pfizer Recent Developments
Table 102. Johnson & Johnson Company Information
Table 103. Johnson & Johnson Introduction and Business Overview
Table 104. Johnson & Johnson Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 105. Johnson & Johnson Enflurane Product Offerings
Table 106. Johnson & Johnson Recent Developments
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 110. Merck Enflurane Product Offerings
Table 111. Merck Recent Developments
Table 112. Roche Company Information
Table 113. Roche Introduction and Business Overview
Table 114. Roche Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 115. Roche Enflurane Product Offerings
Table 116. Roche Recent Developments
Table 117. Novartis Company Information
Table 118. Novartis Introduction and Business Overview
Table 119. Novartis Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021–2026)
Table 120. Novartis Enflurane Product Offerings
Table 121. Novartis Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Key Suppliers of Raw Materials Lists
Table 124. Enflurane Downstream Customers
Table 125. Enflurane Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Enflurane Product Picture
Figure 2. Global Enflurane Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Enflurane Sales Value (US$ Million), 2021–2032
Figure 4. Global Enflurane Sales Volume (MT), 2021–2032
Figure 5. Global Enflurane Sales Price (USD/MT), 2021–2032
Figure 6. Enflurane Report Years Considered
Figure 7. Global Enflurane Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Enflurane Sales Volume Ranking of Players (MT), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enflurane Revenue in 2025
Figure 10. Enflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Pharmaceutical Grade Enflurane Picture
Figure 12. Industrial Grade Enflurane Picture
Figure 13. Global Enflurane Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Enflurane Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Enflurane Sales Volume by Type (MT), 2021 vs 2025 vs 2032
Figure 16. Global Enflurane Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Enflurane Price by Type (USD/MT), 2021–2032
Figure 18. Product Picture of Medicine
Figure 19. Product Picture of Chemical Industry
Figure 20. Product Picture of Others
Figure 21. Global Enflurane Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Enflurane Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Enflurane Sales Volume by Application (MT), 2021 vs 2025 vs 2032
Figure 24. Global Enflurane Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Enflurane Price by Application (USD/MT), 2021–2032
Figure 26. North America Enflurane Sales Value (US$ Million), 2021–2032
Figure 27. North America Enflurane Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Enflurane Sales Value (US$ Million), 2021–2032
Figure 29. Europe Enflurane Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Enflurane Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Enflurane Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Enflurane Sales Value (US$ Million), 2021–2032
Figure 33. South America Enflurane Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Enflurane Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Enflurane Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Enflurane Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Enflurane Sales Volume (%), 2021–2032
Figure 38. United States Enflurane Sales Value (US$ Million), 2021–2032
Figure 39. United States Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Enflurane Sales Value (US$ Million), 2021–2032
Figure 42. Europe Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 44. China Enflurane Sales Value (US$ Million), 2021–2032
Figure 45. China Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 46. China Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Enflurane Sales Value (US$ Million), 2021–2032
Figure 48. Japan Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Enflurane Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Enflurane Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 56. India Enflurane Sales Value (US$ Million), 2021–2032
Figure 57. India Enflurane Sales Value by Type (%), 2025 vs 2032
Figure 58. India Enflurane Sales Value by Application (%), 2025 vs 2032
Figure 59. Enflurane Industrial Chain
Figure 60. Enflurane Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Enflurane market?
The top companies in the global Enflurane market are Baxter、J&TEC、GE Healthcare.
Related Reports
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enflurane market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 94
USD 4250.00
(Single User License)
Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 162
USD 4900.00
(Single User License)
Global Enflurane Market Research Report 2026
The global Enflurane market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 137
USD 2900.00
(Single User License)
Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 158
USD 4900.00
(Single User License)
Global Enflurane Market Insights, Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2025-06-16
Pages: 168
USD 4900.00
(Single User License)
Enflurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 111
USD 3950.00
(Single User License)
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enflurane market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 98
USD 4250.00
(Single User License)
Global Enflurane Market Research Report 2025
The global market for Enflurane was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-16
Pages: 102
USD 2900.00
(Single User License)
Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 3950.00
(Single User License)
Global Enflurane Market Insights, Forecast to 2030
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
Published Date: 2024-04-19
Pages: 97
USD 4900.00
(Single User License)
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enflurane market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 94
USD 4250.00 (Single User License)Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 162
USD 4900.00 (Single User License)Global Enflurane Market Research Report 2026
The global Enflurane market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 137
USD 2900.00 (Single User License)Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 158
USD 4900.00 (Single User License)Global Enflurane Market Insights, Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2025-06-16
Pages: 168
USD 4900.00 (Single User License)Enflurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 111
USD 3950.00 (Single User License)Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enflurane market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 98
USD 4250.00 (Single User License)Global Enflurane Market Research Report 2025
The global market for Enflurane was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-16
Pages: 102
USD 2900.00 (Single User License)Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
USD 3950.00 (Single User License)Global Enflurane Market Insights, Forecast to 2030
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
Published: 2024-04-19
Pages: 97
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now